These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 16020115)

  • 41. Skeletal morbidity in childhood acute lymphoblastic leukemia.
    Mandel K; Atkinson S; Barr RD; Pencharz P
    J Clin Oncol; 2004 Apr; 22(7):1215-21. PubMed ID: 15051768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bisphosphonate therapy for reduced bone mineral density during treatment of acute lymphoblastic leukemia in childhood and adolescence: a report of preliminary experience.
    Lethaby C; Wiernikowski J; Sala A; Naronha M; Webber C; Barr RD
    J Pediatr Hematol Oncol; 2007 Sep; 29(9):613-6. PubMed ID: 17805035
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence and predictors of osteopenia and osteoporosis in adults with Type 1 diabetes.
    Hamilton EJ; Rakic V; Davis WA; Chubb SA; Kamber N; Prince RL; Davis TM
    Diabet Med; 2009 Jan; 26(1):45-52. PubMed ID: 19125760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bone mineral density in patients with growth hormone deficiency: does a gender difference exist?
    Hitz MF; Jensen JE; Eskildsen PC
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):783-91. PubMed ID: 17121531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.
    Lange U; Teichmann J; Müller-Ladner U; Strunk J
    Rheumatology (Oxford); 2005 Dec; 44(12):1546-8. PubMed ID: 16263785
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Bone mineral density and markers of bone turnover in patients treated for malignant disease in childhood].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M; Łuczyński W; Kaczmarski M; Wołczynski S; Piotrowska-Jastrzebska J
    Med Wieku Rozwoj; 2004; 8(4 Pt 2):1041-54. PubMed ID: 15951599
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of metabolic bone disease in children with celiac disease is independent of symptoms at diagnosis.
    Turner J; Pellerin G; Mager D
    J Pediatr Gastroenterol Nutr; 2009 Nov; 49(5):589-93. PubMed ID: 19644400
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low bone mineral density is present in newly diagnosed paediatric systemic lupus erythematosus patients.
    Lim SH; Benseler SM; Tyrrell PN; Charron M; Harvey E; Hebert D; Silverman ED
    Ann Rheum Dis; 2011 Nov; 70(11):1991-4. PubMed ID: 21917826
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduced bone density at completion of chemotherapy for a malignancy.
    Arikoski P; Komulainen J; Riikonen P; Jurvelin JS; Voutilainen R; Kröger H
    Arch Dis Child; 1999 Feb; 80(2):143-8. PubMed ID: 10325729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of androgen deprivation therapy on bone mineral density in prostate cancer patients.
    Deng JH; Yang LP; Wang LS; Zhou DF
    Asian J Androl; 2004 Mar; 6(1):75-7. PubMed ID: 15064839
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
    Chiba Y; Onouchi T; Ikeda T; Adachi J; Tamura Y; Horiuchi T
    Gerontology; 2009; 55(3):275-80. PubMed ID: 19158438
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Juvenile osteoporosis: recognizing the risk.
    Key LL; Ries W; Madyastha P; Reed F
    J Pediatr Endocrinol Metab; 2003 May; 16 Suppl 3():683-6. PubMed ID: 12795371
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of bone density in children with Scheuermann's disease.
    Popko J; Konstantynowicz J; Kossakowski D; Kaczmarski M; Piotrowska-Jastrzebska J
    Rocz Akad Med Bialymst; 1997; 42(1):245-50. PubMed ID: 9581488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies.
    Pastores GM; Elstein D; Hrebícek M; Zimran A
    Clin Ther; 2007 Aug; 29(8):1645-54. PubMed ID: 17919546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of osteoporosis/osteopenia in pediatric leukemia and lymphoma.
    Bryant ML; Worthington MA; Parsons K
    Ann Pharmacother; 2009 Apr; 43(4):714-20. PubMed ID: 19336653
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Relationship between bone mineral content and growth disorders in children with juvenile idiopathic arthritis].
    Górska A; Urban M; Konstantynowicz J; Bartnicka M; Chlabicz S; Górski S; Kaczmarski M
    Pol Merkur Lekarski; 2008 Mar; 24(141):227-30. PubMed ID: 18634288
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bone density comparisons in male competitive road cyclists and untrained controls.
    Smathers AM; Bemben MG; Bemben DA
    Med Sci Sports Exerc; 2009 Feb; 41(2):290-6. PubMed ID: 19127198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vertebral compression fractures at the onset of acute lymphoblastic leukemia in a child.
    Oliveri MB; Mautalen CA; Rodriguez Fuchs CA; Romanelli MC
    Henry Ford Hosp Med J; 1991; 39(1):45-8. PubMed ID: 1830297
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peripheral and central measurements of bone mineral density are equally strongly associated with clinical risk factors for osteoporosis.
    Patel R; Blake GM; Fogelman I
    Calcif Tissue Int; 2007 Feb; 80(2):89-96. PubMed ID: 17308990
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of interleukin-1 and -6 in the etiopathogenesis of idiopathic osteoporosis and osteopenia in children.
    Rusińska A; Chlebna-Sokół D
    Arch Immunol Ther Exp (Warsz); 2005; 53(3):257-65. PubMed ID: 15995586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.